Investor Presentation • Mar 14, 2022
Investor Presentation
Open in ViewerOpens in native device viewer

1

2
DISCLAIMER This presentation was prepared by Turpaz Industries Ltd. (the "Company") for the sole purpose of conveying information regarding the Company and its subsidiaries (together with the Company "Turpaz Group"). This presentation does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase any securities of the Company and is intended to provide information only. This presentation is not intended to replace the need to review the Company's full reports to the Securities Authority and the Tel Aviv Stock Exchange Ltd. (hereinafter: "Company Reports") prior to making a decision regarding investment in the Company's securities.
In addition, this presentation cannot replace investment consulting by a lawfully licensed investment consultant.
This presentation includes statements data, forecasts, goals and Company plans that are "forward-looking statements", as defined in the Securities Law - 1968, whose occurrence is not certain, and which are not solely in the Company's control. These forward-looking statements are included, inter alia, in discussions of strategy, objectives, goals, plans, events, future intentions or other information relating to future events or issues whose occurrence is not certain.
By their nature, forward-looking statements involve risk and uncertainty. Whether the forward-looking information occurs or not is affected, inter alia, by risk factors characteristic to the Company's operations and developments in the general environment and external factors which impact the Turpaz Group and its area of activities.
Subject to the requirements of applicable law, the Company does not intend to update any industry information or forward-looking statements appearing in this presentation and is not required to publish any additional presentations for its shareholders in future.
3

Founded in 2011

12 globally Production sites

372 employees 53 in R&D (9 PhD)
Multinational fragrance & flavor house with specialty ingredients site

Scent Taste Pharma intermediates Specialty ingredients
Double digit growth via organic growth and M&A

IPO on TASE in May 2021 & Trade on TA-125 since February 2022
| Sales \$ 85.3M + 61.8% Sales growth + 18.6% Organic growth |
Adjusted EBITDA \$ 20.5M +46% |
Accomplished 4 Acquisitions since IPO (May 2021) |
|---|---|---|
| Net cash flow from operation \$12.3M |
Solid balance sheet supporting growth and acquisitions strategy |
Traded on TA-125 |

P (proforma) - Assuming the acquisitions performed and completed in 2021 had been consolidated on January 1, 2021
| TURPAZ – CONSOLIDATE |
||
|---|---|---|
| In K US \$ / % | 2020 | 2021 |
| Sales | 52,730 | 85,334 |
| 10,185 | 16,040 | |
| Operating profit | 19.3% | 18.8% |
| Organic growth | +18.6% | |
| Highlights | While all other segments show compared to 2020, The flavor activity for the all year 2021 compared than-average profitability and Since completion of the SDA acquisition, while growing, streamlining, and |
significant improved profitability segment ratio increase from 18.5% to only the fourth quarter therefore overall consolidate profitability the company is working synergizing with other activities |


| FRAGRANCES | |||
|---|---|---|---|
| In US K \$ / % | 2020 | 2021 | |
| Sales | 15,144 | 19,436 | |
| Operating profit | 5,054 33.4% |
6,804 35% |
|
| Organic growth | +22.7% | ||
| Acquisitions | Lori (*) | ||
| Highlights | Strong Organic Growth reflects leveraging of synergies |
||
| (*) Completed January 2022 |
| FLAVORS | |||
|---|---|---|---|
| In K US \$ / % | 2020 | 2021 | |
| Sales | 9,717 | 33,291 | |
| Operating profit | 927 9.5% |
2,533 7.6% |
|
| Organic growth | +17.9% | ||
| Acquisitions | WFF, Florasynth, SDA (51%) |
SDA (49%), Pilpel and Galilee Herb, FIT |
|
| Highlights | Improved profitability is expected within the following questers. | SDA's operating profit margin is relatively low compared to the segment profitably. SDA has begun a program to improve its product lines & operational efficiency. |
|

| P- INTERMEDIATES P |
|||
|---|---|---|---|
| In K US \$ / % | 2020 | 2021 | |
| Sales | 14,213 | 20,873 | |
| Operating profit | 3,450 24.3% |
6,615 31.7% |
|
| Organic growth | +46.9% | ||
| Highlights | with high added value | Continue developing products | |
| S - INTERMEDIATES S |
|||
|---|---|---|---|
| In K US \$ / % | 2020 | 2021 | |
| Sales | 13,656 | 11,733 | |
| Operating profit | 3,085 22.6% |
3,317 28.3% |
|
| Organic growth | -14.1% | ||
| Highlights | Continuances improvement of product selection |
||



OHAD BLUSTEIN VP Finance


KAREN COHEN - KHAZON Chairperson & CEO

EYAL AZULAY VP CEO, Chemada

ARI ROSENTHAL VP Food Division



AVISHAI MORDEHOVICH CEO, SDA

CINDY NGUYEN CEO, WFF

MICHAEL REISS President, Pollena Aroma

MOSHE KATZ CEO, Turpaz USA

David Landau CEO, FIT

Alexandr Tjuterev Co-Manager, Lori

Tatjana Kramer Co-Manager, Lori



HAIR CARE

WET WIPES
BODY CARE & TOILETRIES
SCENTED CANDELS

FINE FRAGRANCES

SOFT DRINKS
DIETARY

ICE CREAM

BAKERY



DAIRY
HERBS & SPICES

CITRUS


COSMETICS

HOME FREGRANCES

ORAL CARE

FABRIC CARE
FLAVORS FOR CBD PRODUCTS




















17
Small and medium
in Europe, Asia and
North America
size local businesses

Enhance management capabilities and support

Loyal customers base

Relatively low EBITDA multiples

Revenues – up to \$50 M

Significant growth potential

Significant synergetic advantages

Unique products or technologies



Strengthening research, development & innovation systems

Improving supply chain processes and production arrays

Expanding global marketing & sales network deployment

Fast response to customer needs based on experience

Enhance synergies among the Group

Cross-selling among the Group


21

https://www.perfumerflavorist.com/flavor/trends/news/22093651/flavors-and-fragrances-market-to-reach-373b-by-2026
Scent & taste determine customer decisions ...
... and represent only a minor fraction of costs



Consumer base is growing
IMPACT
23
Living longer and more consciously

Sustainability is of high concern
• Operations (eg. low carbon footprint factories)
COVID-19: E-commerce, self-care and localization gain importance




Vegetarian
Ingrediencies


| K US \$ |
2019 | 2020 | 2021 |
|---|---|---|---|
| Revenues | 32,187 | 52,730 | 85,334 |
| Gross Profit | 11,737 | 21,824 | 34,728 |
| GP% | 36.5%% | 41.4% | 40.7% |
| R&D costs / Expenses | 550 | 862 | 1,949 |
| Sales & Marketing expenses | 2,968 | 3,848 | 6,274 |
| Management & General expenses | 6,820 | 6,625 | 10,257 |
| Other | (4,130) | 304 | 208 |
| Operating Profit | 5,529 | 10,185 | 16,040 |
| OP% | 17.1% | 19.3% | 18.8% |
| Net Profit | 3,969 | 8,131 | 12,812 |
| Adj. EBIDTA | 5,903 | 14,025 | 20,475 |
| % | 18.3% | 26.6% | 24.0% |
| Net Cash flow from operation | 3,065 | 11,151 | 12,283 |
| K US \$ |
31.12.2020 | 31.12.2021 |
|---|---|---|
| Assets | ||
| Current Assets | 35,258 | 106,082 |
| Non -Current Assets |
35,132 | 66,587 |
| Total Assets | 70,390 | 172,669 |
| Liabilities & Equity | ||
| Current Liabilities | 29,121 | 37,032 |
| Non-Current Liabilities | 28,491 | 42,521 |
| Total Equity | 12,778 | 93,116 |
| Total Liabilities and Equity | 70,390 | 172,669 |
Solid balance sheet supporting growth and acquisitions strategy

28

Global F&F company with high profitability

Double digit growth based on organic growth and M&A

Management with vast experience

Operating in a growing industry that benefits from positive drivers that support continued growth

Supplying to all customers (SMB) - ONE STOP SHOP solutions, via customer intimacy

Cash and banks funds growth and acquisitions strategy Dividend distribution - US\$ 3.86 M


Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.